Norbert G. Riedel - 03 Jan 2025 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
Director
Signature
/s/ James R. Gruber
Issuer symbol
ETON
Transactions as of
03 Jan 2025
Net transactions value
+$373,842
Form type
4
Filing time
06 Jan 2025, 16:22:21 UTC
Previous filing
06 Aug 2024
Next filing
11 Aug 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETON Common Stock Options Exercise $98,092 +27,400 +46% $3.58 87,145 03 Jan 2025 Direct
transaction ETON Common Stock Options Exercise $189,000 +50,000 +57% $3.78 137,145 03 Jan 2025 Direct
transaction ETON Common Stock Options Exercise $86,750 +25,000 +18% $3.47 162,145 03 Jan 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETON Employee Stock Option (Right to Buy) Options Exercise $0 -27,400 -100% $0.000000 0 03 Jan 2025 Common Stock 27,400 $3.58 Direct
transaction ETON Employee Stock Option (Right to Buy) Options Exercise $0 -50,000 -100% $0.000000 0 03 Jan 2025 Common Stock 50,000 $3.78 Direct
transaction ETON Employee Stock Option (Right to Buy) Options Exercise $0 -25,000 -100% $0.000000 0 03 Jan 2025 Common Stock 25,000 $3.47 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

The reporting person has authorized and designated the named person to file this Form 4 on the reporting person's behalf for indefinite duration.